Bozena Konopka

Warsaw, MZ 02781, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations.

High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations.

Journal: Cancers

Published: November 22, 2024

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 13, 2020

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Journal: Oncotarget

Published: March 31, 2017

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: August 10, 2016

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Journal: Oncotarget

Published: May 18, 2016

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.

Journal: Oncotarget

Published: June 18, 2015

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

Journal: Orphanet journal of rare diseases

Published: October 13, 2014

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.

Journal: PloS one

Published: February 09, 2014

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: December 31, 2013

p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Journal: Cancer biology & therapy

Published: September 12, 2013

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

Journal: Human pathology

Published: September 28, 2009

Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.

Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.

Journal: Journal of cancer research and clinical oncology

Published: July 18, 2006

Showing 1-12 of 13

Last Updated: 09/26/2026